Rhythm Pharmaceuticals Inc Cash Flow-to-Debt Ratio
Rhythm Pharmaceuticals Inc cash flow-to-debt ratio. Rhythm Pharmaceuticals Inc (RYTM) has a Cash Flow-to-Debt Ratio of -0.07x as of December 2025, meaning its operating cash flow of $-25.39 Million could theoretically repay 0% of its total liabilities ($342.12 Million) in one year. See RYTM free cash flow debt coverage to measure the company's free cash flow as a share of total liabilities.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cash Flow-to-Debt Ratio of Rhythm Pharmaceuticals Inc (2012–2025)
Cash flow-to-debt ratio of Rhythm Pharmaceuticals Inc from 2012 to 2025. Historical debt coverage capacity for Rhythm Pharmaceuticals Inc across 14 annual periods. Check Rhythm Pharmaceuticals Inc (RYTM) cash flow quality to evaluate the quality of earnings relative to operating cash generation.
Rhythm Pharmaceuticals Inc Cash Flow-to-Debt Ratio by Year (2012–2025)
Rhythm Pharmaceuticals Inc cash flow-to-debt ratio by year from 2012 to 2025. Year-by-year debt coverage analysis for Rhythm Pharmaceuticals Inc. For the full cash flow conversion analysis, see Rhythm Pharmaceuticals Inc cash flow conversion.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -0.34x | $-115.67 Million | $342.12 Million | ▲ +32.4% |
| 2024 | -0.50x | $-113.88 Million | $227.72 Million | ▲ +40.1% |
| 2023 | -0.84x | $-136.16 Million | $162.99 Million | ▲ +43.1% |
| 2022 | -1.47x | $-173.43 Million | $118.22 Million | ▲ +54.4% |
| 2021 | -3.22x | $-146.00 Million | $45.37 Million | ▲ +45.8% |
| 2020 | -5.94x | $-121.98 Million | $20.55 Million | ▼ -33.0% |
| 2019 | -4.46x | $-122.75 Million | $27.50 Million | ▼ -0.4% |
| 2018 | -4.45x | $-62.06 Million | $13.95 Million | ▼ -4.9% |
| 2017 | -4.24x | $-29.46 Million | $6.95 Million | ▲ +7.9% |
| 2016 | -4.61x | $-23.22 Million | $5.04 Million | ▼ -248.1% |
| 2015 | -1.32x | $-6.98 Million | $5.27 Million | ▲ +90.3% |
| 2014 | -13.60x | $-7.51 Million | $552.00K | ▼ -5271.1% |
| 2013 | -0.25x | $-19.16 Million | $75.65 Million | ▲ +21.6% |
| 2012 | -0.32x | $-17.83 Million | $55.21 Million | — |